Colostrum from MERS-CoV seropositive camels for MERS prophylaxis and SARS-CoV-2 infection, a placebo controlled randomized trial
Hagit Masika(Hebrew University of Jerusalem), Hila Elinav(Hebrew University of Jerusalem), Jacob Strahilevitz(Hebrew University of Jerusalem), Matan Golan(Soroka Medical Center), Yonatan Oster(Hadassah Medical Center), Alexander Rouvinski(Atkins (United States)), Einav Cohen‐Kfir(Hebrew University of Jerusalem), Meir Cherniak(Hebrew University of Jerusalem), Orna Mor(Sheba Medical Center), Dan David, Jamal Fahoum(Hebrew University of Jerusalem), Elena Britan‐Rosich(Hebrew University of Jerusalem), Moshe Dessau(Bar-Ilan University), Ahmad Nama(Hadassah Medical Center), Joel Alter(Bar-Ilan University), Eitan Israeli(Hebrew University of Jerusalem), Batel Nissan(Hebrew University of Jerusalem), David Planer(Hadassah Medical Center), Saveliy Kirillov(L. N. Gumilyov Eurasian National University), Sujata Kumari(Hebrew University of Jerusalem), Daniel Grupel(Ben-Gurion University of the Negev), Reaan Amer(Hadassah Medical Center), Reuven Wiener(Hebrew University of Jerusalem)
Cited by 1
Related Papers
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930
<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States
|Antimicrobial Agents and Chemotherapy|2006|576
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
|Nature Immunology|2014|497
Plasmid-Mediated Quinolone Resistance
|Microbiology Spectrum|2014|469